Crossmark

Development of Competitive ELISA and CLEIA for Quantitative Analysis of Polymyxin B

Crossref DOI link: https://doi.org/10.1007/s12161-019-01477-9

Published Online: 2019-02-25

Published Print: 2019-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xu, Long

Burkin, Maksim

Eremin, Sergei

Dias, Alberto C. P.

Zhang, Xiaoying
Funding

Funding for this research was provided by:

the Key Program for International S&T Cooperation Project of Shaanxi Province (2017KW-ZD-10)

national funds through the FCT I.P, the Minist?rio da Ci?ncia, Tecnologia e Ensino Superior (MCTES), the ERDF through the COMPETE2020 - Programa Operacional Competitividade e Internacionaliza??o (POCI-01-0145-FEDER-007569)

the Ministry of Education and Science of the Russian Federation (RFMEFI60417X0198)
License Information

Text and Data Mining valid from 2019-02-25
More Information

Article History

Received: 4 November 2018

Accepted: 13 February 2019

First Online: 25 February 2019

Compliance with Ethical Standards

:

: Long Xu declares that he has no conflict of interest. Maksim Burkin declares that he has no conflict of interest. Sergei Eremin declares that he has no conflict of interest. Alberto C. P. Dias declares that he has no conflict of interest. Xiaoying Zhang declares that he has no conflict of interest.

: All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted.

: Informed consent was obtained from all individual participants included in the study (in case humans are involved).